AstraZeneca aims to be first with full cell therapy capabilities in China
AstraZeneca plans to build a cell therapy manufacturing and supply base, as well as an innovation centre, in Shanghai, according to Reuters. The facility will produce CAR-T cell therapies, a …
AstraZeneca aims to be first with full cell therapy capabilities in China Read More